Tag: Pfizer

High Levels of Circulating Spike Protein Found in Myocarditis Patients Who Took mRNA COVID-19 Vaccine: Study

People who suffered from myocarditis after receiving an mRNA-based COVID-19 vaccine were found to have persistently higher levels of circulating spike protein compared to those who also received an mRNA-based COVID-19 vaccine but did not develop myocarditis, according to findings from a new study. The study, published Jan. 4 in the Journal of the American…


Pharma Companies Including Pfizer, AstraZeneca to Hike Cost of Over 350 Drugs in 2023

The costs of over 350 different drugs are set to rise in the United States this year as multiple pharmaceutical companies, including Pfizer, prepare for President Joe Biden’s Inflation Reduction Act (IRA) to take effect and inflation continues to soar. Pfizer, AstraZeneca, GlaxoSmithKline, Bristol Myers Squibb, and Sanofi are among several drugmakers set to raise prices…


Pharma Companies to Hike Cost of Over 350 Drugs in 2023: Analysis

The costs of over 350 different drugs are set to rise in the United States this year as multiple pharmaceutical companies, including Pfizer, prepare for President Joe Biden’s Inflation Reduction Act (IRA) to take effect and inflation continues to soar. Pfizer, AstraZeneca, GlaxoSmithKline, Bristol Myers Squibb, and Sanofi are among several drugmakers set to raise prices…


Dead Bodies Left at Home for Days: Chinese Funeral Houses Overloaded

Update on China’s sweeping COVID-19 outbreak: Cars are lining up outside funeral homes in major cities, some gathering in the middle of the night. Some families are forced to keep the bodies of their deceased loved ones at home. Overloaded funeral homes now have days-long wait times for services. There’s an unusual death toll among…


Florida Supreme Court to Convene Grand Jury to Investigate COVID-19 Vaccines

The Florida Supreme Court announced Thursday it approved a request by Gov. Ron DeSantis to impanel a statewide grand jury to investigate any wrongdoing related to COVID-19 vaccines. “A statewide grand jury shall be promptly impaneled for a term of twelve calendar months, to run from the date of impanelment, with jurisdiction throughout the State of…


New COVID-19 Boosters Effective Against Hospitalization: CDC Studies

The updated COVID-19 vaccine boosters are effective against hospitalization, at least for a short period of time, according to two new studies from the U.S. Centers for Disease Control and Prevention (CDC). The Pfizer and Moderna bivalent boosters were estimated to be 57 percent effective against COVID-19-associated hospitalizations among adults without certain serious health conditions,…


About 50 Percent of Americans Say They Don’t Need New COVID Booster: Kaiser Poll

About half of the U.S. adult population say they don’t need the latest COVID-19 booster while just under a quarter have already taken the jab, according to a recent poll. The findings come despite a Biden administration push to vaccinate during the holiday season. According to the Kaiser Family Foundation (KFF) COVID-19 Monitor poll, only…


About 50 Percent of Americans Say They Don’t Need New COVID-19 Booster: Kaiser Poll

About half of the U.S. adult population say they don’t need the latest COVID-19 booster while just under a quarter have already taken the jab, according to a recent poll. The findings come despite a Biden administration push to vaccinate during the holiday season. According to the Kaiser Family Foundation (KFF) COVID-19 Monitor poll, only…


Capitol Report: Concerns Over Another Massive Spending Bill Fueling Inflation; TikTok Ban Gaining Bipartisan Support

More than two months past due, lawmakers announce an agreement on a government funding bill for 2023. Republicans are split over whether to squash the bill or to jam it through in the 11th hour. Rep. Scott Perry (R-Pa.) joins us to weigh in on the omnibus and the impending challenge to House Minority Leader…


US to Pay Pfizer $2 Billion for 3.7 Million More Courses of Paxlovid

The United States has struck a deal with Pfizer to pay the pharmaceutical giant almost $2 billion for 3.7 million more courses of Paxlovid. “The additional 3.7 million treatment courses are planned for delivery by early 2023,” the company announced. The Defense Department announced on Dec. 13 that Pfizer was awarded a $1,959,999,848 contract for Paxlovid. “Work…